1
Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus
Condition(s): Type 1 Diabetes Mellitus Last Updated: January 31, 2011Active, not recruiting
79 Clinical Trials for: CTLA-4 Ig, Page 1 of 4
Hide Studies Not Seeking New Volunteers
2
Phase II Randomized, Double-Blind, Placebo-Controlled Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris
Condition(s): Psoriasis Vulgaris Last Updated: April 11, 2011Completed
3
CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Condition(s): Abnormal Glucose Tolerance; Type 1 Diabetes Last Updated: April 2, 2013Recruiting
4
Phase I Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris
Condition(s): Psoriasis Vulgaris Last Updated: April 11, 2011Completed
5
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
Condition(s): Lupus Nephritis; Lupus Erythematosus, Systemic Last Updated: December 6, 2012Active, not recruiting
6
Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.
Condition(s): Rheumatoid Arthritis Last Updated: November 14, 2011Completed
7
Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer
Condition(s): Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Myeloid Leukemia; Recurrent Melanoma; Recurrent Non-small Cell Lung Cancer; Recurrent Ovarian Epithelial Cancer; Stage IV Melanoma; Stage IV Non-small Cell Lung Cancer Last Updated: January 9, 2013Terminated
8
CP-675,206 (CTLA4-Blocking Monoclonal Antibody) Combined With Dendritic Cell Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery
Condition(s): Melanoma (Skin) Last Updated: August 2, 2012Completed
9
Abatacept With Methotrexate- Phase IIB
Condition(s): Rheumatoid Arthritis Last Updated: May 30, 2012Completed
10
Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
Condition(s): Wegener's Granulomatosis Last Updated: February 21, 2013Completed
11
Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis
Condition(s): Takayasu's Arteritis; Giant Cell Arteritis Last Updated: August 27, 2012Recruiting
12
Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis
Condition(s): Rheumatoid Arthritis Last Updated: April 29, 2010Completed
13
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
Condition(s): Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes Last Updated: November 28, 2011Completed
14
A Cooperative Clinical Study of Abatacept in Multiple Sclerosis
Condition(s): Multiple Sclerosis, Relapsing-Remitting Last Updated: March 18, 2013Recruiting
15
Costimulation Inhibition in Asthma
Condition(s): Atopic Asthma Last Updated: May 21, 2012Completed
16
Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Colon Cancer That Has Not Responded to Vaccine Therapy
Condition(s): Lymphoma Last Updated: April 30, 2012Completed
17
Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer
Condition(s): Recurrent Prostate Cancer; Stage IV Prostate Cancer Last Updated: March 18, 2013Active, not recruiting
18
MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma
Condition(s): Adult Grade III Lymphomatoid Granulomatosis; B-cell Chronic Lymphocytic Leukemia; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Refractory Hairy Cell Leukemia; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Waldenström Macroglobulinemia Last Updated: April 8, 2013Completed
19
Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer
Condition(s): Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative; Childhood Myelodysplastic Syndromes; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Disseminated Neuroblastoma; Malignant Neoplasm; Ovarian Choriocarcinoma; Ovarian Embryonal Carcinoma; Ovarian Immature Teratoma; Ovarian Mature Teratoma; Ovarian Mixed Germ Cell Tumor; Ovarian Monodermal and Highly Specialized Teratoma; Ovarian Polyembryoma; Ovarian Yolk Sac Tumor; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Malignant Testicular Germ Cell Tumor; Recurrent Mantle Cell Lymphoma; Recurrent Neuroblastoma; Recurrent Ovarian Epithelial Cancer; Recurrent Ovarian Germ Cell Tumor; Refractory Chronic Lymphocytic Leukemia; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage II Ovarian Epithelial Cancer; Stage III Malignant Testicular Germ Cell Tumor; Stage III Multiple Myeloma; Stage III Ovarian Epithelial Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer; Stage IV Ovarian Epithelial Cancer; Testicular Choriocarcinoma; Testicular Choriocarcinoma and Embryonal Carcinoma; Testicular Choriocarcinoma and Seminoma; Testicular Choriocarcinoma and Teratoma; Testicular Choriocarcinoma and Yolk Sac Tumor; Testicular Embryonal Carcinoma; Testicular Embryonal Carcinoma and Seminoma; Testicular Embryonal Carcinoma and Teratoma; Testicular Embryonal Carcinoma and Teratoma With Seminoma; Testicular Embryonal Carcinoma and Yolk Sac Tumor; Testicular Embryonal Carcinoma and Yolk Sac Tumor With Seminoma; Testicular Teratoma; Testicular Yolk Sac Tumor; Testicular Yolk Sac Tumor and Teratoma; Testicular Yolk Sac Tumor and Teratoma With Seminoma Last Updated: March 26, 2013Completed
20
Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma
Condition(s): Recurrent Melanoma; Stage IV Melanoma Last Updated: February 4, 2013Recruiting
